Pharmacological characterization of 5-substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: novel antagonists for the histamine H3 and H4 receptors with anti-inflammatory potential (2017)
- Authors:
- Autor USP: COSTA NETO, CLAUDIO MIGUEL DA - FMRP
- Unidade: FMRP
- DOI: 10.3389/fphar.2017.00825
- Subjects: ANTAGONISTAS; ANTI-INFLAMATÓRIOS; ASMA; RECEPTORES; HISTAMINA
- Keywords: H3R antagonists; H4R antagonists; SAR; Anti-inflammatory activity; Asthma; Dihydrobenzofuran; Histamine receptors
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 8, art. 825, 2017
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
CORRÊA, Michelle F. et al. Pharmacological characterization of 5-substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: novel antagonists for the histamine H3 and H4 receptors with anti-inflammatory potential. Frontiers in Pharmacology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fphar.2017.00825. Acesso em: 09 abr. 2026. -
APA
Corrêa, M. F., Barbosa, Á. J. R., Teixeira, L. B., Duarte, D. A., Simões, S. C., Silva, L. T. P. e, et al. (2017). Pharmacological characterization of 5-substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: novel antagonists for the histamine H3 and H4 receptors with anti-inflammatory potential. Frontiers in Pharmacology, 8. doi:10.3389/fphar.2017.00825 -
NLM
Corrêa MF, Barbosa ÁJR, Teixeira LB, Duarte DA, Simões SC, Silva LTP e, Balbino AM, Landgraf RG, Bouvier M, Costa Neto CM, Fernandes JPS. Pharmacological characterization of 5-substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: novel antagonists for the histamine H3 and H4 receptors with anti-inflammatory potential [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2026 abr. 09 ] Available from: https://doi.org/10.3389/fphar.2017.00825 -
Vancouver
Corrêa MF, Barbosa ÁJR, Teixeira LB, Duarte DA, Simões SC, Silva LTP e, Balbino AM, Landgraf RG, Bouvier M, Costa Neto CM, Fernandes JPS. Pharmacological characterization of 5-substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: novel antagonists for the histamine H3 and H4 receptors with anti-inflammatory potential [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2026 abr. 09 ] Available from: https://doi.org/10.3389/fphar.2017.00825 - Regulação da expressão de receptores de cininas por TLR2
- Benzopyrans from Curvularia sp., an endophytic fungus associated with Ocotea corymbosa (Lauraceae)
- Different binging modes of angiotensin II and [SAR1] angII to the ATI receptor
- Sustained G'alfa's signaling mediated by vasopressin type 2 receptors is ligand dependent but endocytosis and 'beta'-arrestin independent
- Synthesis, characterization and initial biological studies of a new platinum (II) complex with deoxyalliin
- Participation of transmembrane proline 82 in angiotensin II 'AT IND.1' receptor signal transduction
- Bradykinin-related peptides from Phyllomedusa hypochondrialis
- Stimulation of IL-6 cytokines in fibroblasts by Toll-like receptors 2
- Analysis of structural requirements of the receptor AT1 in activation of AKT and ERK 1/2 signaling pathways: role of EGFR transactivation
- Up regulation of 'B IND.1' receptors in an experimental model of muscle atrophy
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
